Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sainty Pharma appears to be a commercial pharmaceutical brand used in connection with Jiangsu Sainty Handsome Co., Ltd., a China-based subsidiary of Jiangsu Sainty Group. Publicly available sources describe Sainty Pharma as focused on the manufacture, supply, and export of active pharmaceutical ingredients, pharmaceutical intermediates, finished drugs, veterinary bulk drugs, and feed additives rather than novel drug discovery. The business seems to operate primarily as a pharmaceutical manufacturing and trading organization serving international markets. Based on the available evidence, it does not appear to be a clinical-stage biotech with a disclosed therapeutic pipeline, platform technology, or named R&D assets. The requested name "Sainty Pharma" likely refers to a brand/business unit rather than a standalone biotech or pharma development company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sainty Pharma.